Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca owes $192M in royalties from massive Merck deal, selumetinib licensor Array argues
AstraZeneca owes $192M in royalties from massive Merck deal, selumetinib licensor Array argues
AstraZeneca owes $192M in royalties from massive Merck deal, selumetinib licensor Array argues
Submitted by
admin
on March 21, 2018 - 9:19am
Source:
Fierce Pharma
News Tags:
AstraZeneca
Merck
selumetinib
Array Biopharma
Headline:
AstraZeneca owes $192M in royalties from massive Merck deal, selumetinib licensor Array argues
Do Not Allow Advertisers to Use My Personal information
